首页> 外文期刊>Journal of Clinical Pathology >Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer
【24h】

Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer

机译:对肿瘤抗原的免疫反应:对癌症抗原特异性免疫疗法的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Tumour associated antigens recognised by cellular or humoral effectors of the im- mune system are potential targets for antigen specific cancer immunotherapy. Different categories of cancer antigens Have been identified that induce cytotoxic T lymphocyte (CTL) responses in vitro And in vivo, namely: (1) "cancer testis" (CT) antigens, expressed in different tu- morus and normal testis, (2) melanocyte differentiation antigens, (3) point muta- tions of normal genes, (4) self antigens that are overexpressed in malignant tis- sues, and (5) viral antigens.
机译:被免疫系统的细胞或体液效应子识别的肿瘤相关抗原是抗原特异性癌症免疫治疗的潜在靶标。已经确定了在体外和体内诱导细胞毒性T淋巴细胞(CTL)反应的不同类别的癌症抗原,即:(1)在不同的睾丸和正常睾丸中表达的“癌睾丸”(CT)抗原,(2)黑色素细胞分化抗原,(3)正常基因的点突变,(4)在恶性组织中过表达的自身抗原和(5)病毒抗原。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号